Pandora Wealth Inc. Makes New $757,000 Investment in Relx Plc (NYSE:RELX)

Key Points

• Pandora Wealth Inc. has acquired 15,015 shares of Relx Plc for approximately $757,000 in the first quarter, marking a new investment in the company.
• Institutional investors have significantly increased their stakes in Relx, with Ameriprise Financial growing its stake by 368.7% in the 4th quarter.
• Recently, several analysts upgraded Relx's stock rating, with Wall Street Zen moving from a "hold" to a "buy" rating, indicating a strong confidence in the company's performance.

Pandora Wealth Inc. acquired a new position in shares of Relx Plc (NYSE:RELX - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 15,015 shares of the technology company's stock, valued at approximately $757,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Ameriprise Financial Inc. grew its stake in Relx by 368.7% in the 4th quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company's stock valued at $127,437,000 after acquiring an additional 2,208,119 shares during the period. Northern Trust Corp grew its stake in Relx by 51.6% in the 4th quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company's stock valued at $99,542,000 after acquiring an additional 745,532 shares during the period. GAMMA Investing LLC grew its stake in Relx by 6,125.5% in the 1st quarter. GAMMA Investing LLC now owns 679,073 shares of the technology company's stock valued at $34,232,000 after acquiring an additional 668,165 shares during the period. Bank of Montreal Can grew its stake in Relx by 290.3% in the 4th quarter. Bank of Montreal Can now owns 886,758 shares of the technology company's stock valued at $40,277,000 after acquiring an additional 659,547 shares during the period. Finally, Carnegie Investment Counsel acquired a new stake in Relx in the 1st quarter valued at $16,026,000. Institutional investors and hedge funds own 15.02% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Wall Street Zen upgraded Relx from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Morgan Stanley reiterated an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy".

Relx Stock Performance

Shares of Relx stock opened at $48.00 on Friday. Relx Plc has a one year low of $44.19 and a one year high of $56.33. The company has a market cap of $88.16 billion, a PE ratio of 25.81, a P/E/G ratio of 3.22 and a beta of 0.88. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47. The business has a 50-day simple moving average of $52.80 and a 200-day simple moving average of $51.59.

Relx Cuts Dividend

The company also recently disclosed a semi-annual dividend, which will be paid on Tuesday, September 16th. Shareholders of record on Friday, August 8th will be paid a $0.2634 dividend. The ex-dividend date is Friday, August 8th. This represents a yield of 170.0%. Relx's payout ratio is currently 65.05%.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.